A few new ones coming...

[Peloma]

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

www.pharmavoice.com

 

[Calm Logic]

Cool. Good reminder there about survo:

Most recently, the company completed enrollment for all its phase 3 obesity trials for survodutide. The company is expecting topline trial readouts early next year for survodutide and petrelintide.

 

[Peloma]

Ok... what is CT-388 and petrelintide? I have no idea what these are, but if they're already in trials, I need them for my own research purposes...

 

[Karma-Electron]

Interesting article. Thanks. I feel like I should be investing in some of these companies- then it would be like getting GLP-1s and other peptides for free.